Primary prevention could reduce heart disease among type 2 diabetes patients

August 7, 2017, American College of Cardiology
In a Journal of the American College of Cardiology state of the art review published today, researchers from the division of cardiology and the Center for the Prevention of Cardiovascular Disease at the New York University Medical Center in New York City, examine evidence and guidelines for the prevention of heart disease in Type 2 Diabetes patients. Credit: Newman, J.D. et al. J Am Coll Cardiol. 2017;70(7):883-93.

In a Journal of the American College of Cardiology state of the art review published today, researchers from the division of cardiology and the Center for the Prevention of Cardiovascular Disease at the New York University Medical Center in New York City, examine evidence and guidelines for the prevention of heart disease in Type 2 Diabetes patients.

Type 2 Diabetes Mellitus is one of the leading risk factors for and the most common cause of death in patients with Type 2 Diabetes. According to the Centers for Disease Control and Prevention, approximately 1 in 3 U.S. individuals may have Type 2 Diabetes by 2050. These patients will comprise an increasingly large portion of the heart disease population. However, less than 50 percent of U.S. adults with Type 2 Diabetes meet recommended guidelines for heart disease prevention.

The researchers wrote, "cardiovascular risk reduction is critically important for the care of patients with diabetes, with or without known CVD and CV risk factors." They state the use of proven medical therapies, such as statins, aspirin and glucose lowering therapies, should be considered along with lifestyle management including exercise, nutrition and weight management, for all Type 2 Diabetes patients. This has the potential to significantly reduce the burden of heart disease among these patients.

Explore further: Researchers call for paradigm shift in type 2 diabetes treatment

More information: Journal of the American College of Cardiology (2017). DOI: 10.1016/j.jacc.2017.07.001

Related Stories

Researchers call for paradigm shift in type 2 diabetes treatment

June 20, 2017
Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type 2 diabetes management ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

Major study heralds new era in treatment of type 2 diabetes

June 13, 2017
A drug that lowers blood sugar levels for people with type 2 diabetes has also been revealed to significantly reduce the risk of both cardiovascular and kidney disease.

Fenofibrate may reduce heart disease risk in some patients with type 2 diabetes

December 28, 2016
A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of "good" cholesterol, despite being treated ...

Lipid tx cuts cardiovascular risk with type 1 diabetes

April 22, 2016
(HealthDay)—The risk of cardiovascular disease (CVD) and cardiovascular death is 22 to 44 percent lower among individuals with type 1 diabetes treated with lipid-lowering therapy (LLT), according to a study published online ...

Most patients at diabetes risk consider themselves healthy

January 24, 2014
(HealthDay)—Nearly 80 percent of patients at elevated risk for type 2 diabetes think they are in excellent or very good health, according to a new survey from the American Diabetes Association (ADA).

Recommended for you

A novel insulin accelerant

October 17, 2018
Insulin levels rise after eating a meal, signaling uptake of circulating glucose by skeletal muscle. In individuals with diabetes this process is often impaired—a condition known as insulin resistance.

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.